The burden of hepatitis C virus infection is growing: A Canadian population-based study of hospitalizations from 1994 to 2004

被引:39
作者
Myers, Robert P. [1 ]
Liu, MingFu [2 ]
Shaheen, Abdel Aziz M. [1 ]
机构
[1] Univ Calgary, Liver Unit, Div Gastroenterol, Dept Med, Calgary, AB T2N 4N1, Canada
[2] Calgary Hlth Reg, Hlth Syst Anal Unit, Calgary, AB, Canada
关键词
burden of illness; cirrhosis; database; epidemiology; outcome study; trends;
D O I
10.1155/2008/173153
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: Nearly 1% of Canadians are infected with the hepatitis C virus (HCV). Simulation analyses have suggested that HCV will place an increasing burden on the health care system as the infected population ages, but supportive clinical data are limited. OBJECTIVES: To study temporal trends in HCV-related hospitalizations and predictors of increased health care utilization from a Canadian population-based perspective. METHODS: An administrative hospitalization database from the Calgary Health Region was used to identify patients who were admitted for HCV between 1994 and 2004. The primary outcomes were liver-related HCV hospitalizations, length of stay, hospital costs and in-hospital mortality. Average annual growth rates in outcomes were calculated and subgroup analyses were conducted according to age, sex and HIV/HCV coinfection status. RESULTS: Between 1994 and 2004, there were 4002 HCV-related hospitalizations; 22% were liver-related. Liver-related hospitalizations, lengths of stay and in hospital mortality increased approximately fourfold or an average of 15% to 18% annually (P<0.0005). Patients aged 40 to 59 years and HIV/HCV coinfected patients experienced the largest average annual growth rates (19% to 27% and 30% to 40%, respectively; P<0.0005), reflecting the accelerated natural history of HCV in these subgroups. Hospital costs for livers related HCV hospitalizations increased by an average of 41% annually (P=0.001) between 2000 and 2004. The average annual increase in liver-related hospitalizations remained significant in a sensitivity analysis, even when 75% of HCV cases were under-reported in 1994. CONCLUSIONS: The present studies' findings confirm the growing burden of HCV on the Canadian health care system. Strategies to prevent HCV infection and maximize the dissemination and most effective use of potentially curative antiviral therapies are necessary to reduce these trends.
引用
收藏
页码:381 / 387
页数:7
相关论文
共 40 条
[21]   Outcome of hospital care of liver disease associated with hepatitis C in the United States [J].
Kim, WR ;
Gross, JB ;
Poterucha, JJ ;
Locke, GR ;
Dickson, ER .
HEPATOLOGY, 2001, 33 (01) :201-206
[22]   AN ASSAY FOR CIRCULATING ANTIBODIES TO A MAJOR ETIOLOGIC VIRUS OF HUMAN NON-A, NON-B-HEPATITIS [J].
KUO, G ;
CHOO, QL ;
ALTER, HJ ;
GITNICK, GL ;
REDEKER, AG ;
PURCELL, RH ;
MIYAMURA, T ;
DIENSTAG, JL ;
ALTER, MJ ;
STEVENS, CE ;
TEGTMEIER, GE ;
BONINO, F ;
COLOMBO, M ;
LEE, WS ;
KUO, C ;
BERGER, K ;
SHUSTER, JR ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :362-364
[23]   Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial [J].
Manns, MP ;
McHutchison, JG ;
Gordon, SC ;
Rustgi, VK ;
Shiffman, M ;
Reindollar, R ;
Goodman, ZD ;
Koury, K ;
Ling, MH ;
Albrecht, JK .
LANCET, 2001, 358 (9286) :958-965
[24]   Determinants of antiviral treatment initiation in a hepatitis C-infected population benefiting from universal health care coverage [J].
Moirand, Romain ;
Bilodeau, Marc ;
Brissette, Suzanne ;
Bruneau, Julie .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 21 (06) :355-361
[25]   A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection [J].
Muir, AJ ;
Provenzale, D .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 34 (03) :268-271
[26]  
Pawlotsky JM, 2006, ANTIVIR THER, V11, P397
[27]   Trends of hepatitis B and hepatitis C mortality in Canada, 1979-1997 [J].
Pohani, G ;
Zou, SM ;
Tepper, M .
CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2001, 92 (04) :250-254
[28]   Natural history of liver fibrosis progression in patients with chronic hepatitis C [J].
Poynard, T ;
Bedossa, P ;
Opolon, P .
LANCET, 1997, 349 (9055) :825-832
[29]   Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C [J].
Poynard, T ;
Ratziu, V ;
Charlotte, F ;
Goodman, Z ;
McHutchison, J ;
Albrecht, J .
JOURNAL OF HEPATOLOGY, 2001, 34 (05) :730-739
[30]   Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection [J].
Qurishi, N ;
Kreuzberg, C ;
Lüchters, G ;
Effenberger, W ;
Kupfer, B ;
Sauerbruch, T ;
Rockstroh, JK ;
Spengler, U .
LANCET, 2003, 362 (9397) :1708-1713